Table 1 Characteristics of patients and controls
Ebstein’s anomaly(N = 44) | Healthy Subjects(N = 44) | P value | |
|---|---|---|---|
Age, yrs | 34.0 ± 16.2 | 33.3 ± 16.1 | 0.923 |
10 ≤ age ≤ 18, yrs | 7(15.9) | 7 (15.9) | 1.000 |
Male (n, %) | 18(40.9) | 18 (40.9) | 1.000 |
BSA, m2 | 1.5 ± 0.2 | 1.6 ± 0.2 | 0.468 |
BMI, kg/m2 | 21.8 ± 4.8 | 21.7 ± 3.5 | 0.932 |
Heart rate, bpm | 83.3 ± 12.7 | 73.6 ± 11.6 | < 0.001 |
SO2 at rest, % | 96.6 ± 2.6 | 99.0 ± 1.0 | < 0.001 |
Hematocrit, % | 42.5 ± 4.9 | 44.1 ± 5.2 | 0.071 |
ASD/PFO (n, %) | 29 (65.9) | 0 | – |
W-P-W (n, %) | 6 (13.6) | 0 | – |
Tricuspid regurgitation severity (n, %) | – | ||
Moderate | 12 (27.3) | 0 | – |
Severe | 32 (72.7) | 0 | – |
Carpentier’s classification | |||
Type A | 18 (40.9) | – | – |
Type B | 17 (38.6) | – | – |
Type C | 8 (18.2) | – | – |
Type D | 1 (2.3) | – | – |
NYHA functional classification (n, %) | |||
I | 10 (22.7) | – | – |
II | 29 (65.9) | – | – |
III | 5 (11.4) | – | – |